ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2018 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
Q1 2017 | $3,000 | -75.0% | 500 | -75.0% | 0.00% | – |
Q4 2016 | $12,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2016 | $15,000 | -11.8% | 2,000 | 0.0% | 0.00% | – |
Q2 2016 | $17,000 | +30.8% | 2,000 | 0.0% | 0.00% | – |
Q1 2016 | $13,000 | -23.5% | 2,000 | 0.0% | 0.00% | – |
Q4 2015 | $17,000 | +240.0% | 2,000 | +100.0% | 0.00% | – |
Q3 2015 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
Q2 2015 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2015 | $6,000 | +100.0% | 1,000 | +171.0% | 0.00% | – |
Q3 2014 | $3,000 | – | 369 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 801,242 | $3,876,000 | 0.50% |
ARMISTICE CAPITAL, LLC | 624,000 | $3,039,000 | 0.18% |
Rossmore Private Capital | 15,061 | $73,000 | 0.03% |
Sterling Investment Advisors, Ltd. | 3,150 | $15,000 | 0.01% |
Squarepoint Ops LLC | 14,500 | $71,000 | 0.00% |
JFS WEALTH ADVISORS, LLC | 500 | $2,000 | 0.00% |
Close Asset Management Ltd | 2,000 | $10,000 | 0.00% |
GROUP ONE TRADING, L.P. | 16,900 | $82,000 | 0.00% |
SIMPLEX TRADING, LLC | 547 | $2,000 | 0.00% |
Tower Research Capital LLC (TRC) | 861 | $4,000 | 0.00% |